REGENERO
Regenero specializes in the development and commercialization of innovative cellular therapies.
REGENERO
Status:
Active
Similar Organizations
MedCap Funds
MedCap Funds invests in the development and commercialization of medical technology companies.
TrioxBio
TrioxBio specializes in the development and commercialization of proprietary synthetic small molecules.
Current Employees Featured
More informations about "Regenero"
About Regeneron | Our Company
About Regeneron. Our mission is to use the power of science to bring new medicines to patients ... over and over again. We are a leading biotechnology company that invents, develops and commercializes life-transforming …See details»
Regeneron Pharmaceuticals - Wikipedia
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.The company was founded in 1988. [2] Originally focused on neurotrophic factors and their regenerative …See details»
Regeneron Canada: Push the Bounds of Science
Regeneron-invented medicines are available in over 100 countries and are being studied in clinical trials in approximately 60 countries. Our unique ability to repeatedly and consistently translate science into medicine has led to …See details»
CORPORATE RESPONSIBILITY - Regeneron …
Our responsibility strategy uses Regeneron’s unique knowledge and expertise to address the issues that matter most to our business and our stakeholders. Guided by our corporate philosophy of “Doing Well by Doing Good,” our …See details»
Regeneron Corporate Presentation
Feb 4, 2025 Regeneron's filings with the U.S. Securities and Exchange Commission. A more complete description of these and other material risks can be found in Regeneron's filings with …See details»
Regenero Website
Regenero also generates biodiversity credits through habitat restoration, creating a sustainable funding model. We collaborate with scientific institutions to monitor and verify biodiversity …See details»
Regeneron - Leadership Team - The Org
The Leadership Team at Regeneron Pharmaceuticals is responsible for guiding the strategic direction and operational execution of the company. Comprising senior executives from …See details»
Regenero
REGENERO está formado por Cells for Cells, Clínica Dávila y Universidad de los Andes, más una sólida red de colaboración científica y comercial internacional. Adicionalmente, el 18 de …See details»
Regeneron - The Org
Regeneron Pharmaceuticals is focused on the development of pharmaceutical products for the treatment of serious medical conditions.See details»
Regenero - Crunchbase Company Profile & Funding
Regenero specializes in the development and commercialization of innovative cellular therapies.See details»
REGENERON EXPANDS PRESENCE IN CANADA BY …
Jan 21, 2025 Regeneron is a leading biotechnology company that was founded and is led by physician-scientists to translate science into medicines. This has led to the development of numerous approved ...See details»
Inclusion & Culture | Regeneron
At Regeneron, we are driven by a strong sense of purpose. Fostering diversity and inclusion is core to our mission, our culture and our commitment to patients. Our approach provides a …See details»
REGENERON EXPANDS PRESENCE IN CANADA BY OPENING ITS …
Jan 21, 2025 Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. ...See details»
Regeneron's 2025 Responsibility Goals
“Regeneron was founded on the philosophy of ‘Doing Well by Doing Good’ because our founders believed it was crucial to achieving our mission of improving people’s lives. This ethos …See details»
Regeneron Provides Business Updates and Highlights from Broad …
Jan 13, 2025 Dupixent ® is now used to treat over a million patients globally, with continued growth and expansion in multiple indications for diseases in which type 2 inflammation plays a role. EYLEA HD ® and EYLEA ® remained the U.S. anti-VEGF category leader in 2024; aggregate U.S. net product sales were $6 billion for full-year 2024, up 1% based on …See details»
Regeneron Manages Clinical Costs In A Fast-Growing Organization
May 1, 2019 Bari Kowal, VP and head of global clinical operations at Regeneron, says sponsors and CROs must partner to make clinical trial execution more efficient and cost-effective. ...See details»
Regeneron Pharmaceuticals | World Economic Forum
The World Economic Forum is an independent international organization committed to improving the state of the world by engaging business, political, academic and other leaders of society to …See details»
FUJIFILM signs $3B deal with Regeneron for biologics work in …
4 days ago FUJIFILM Diosynth Biotechnologies, a global contract development and manufacturing organization (CDMO) with major operations in North Carolina, has signed an …See details»
Oncology & Hematology | Regeneron
Cancer research has come a long way since Regeneron first opened its doors 35 years ago. It’s exciting to be one of the companies at the forefront of cancer research. Hear Matthew Fury, …See details»
FUJIFILM Diosynth Biotechnologies and Regeneron Sign a 10-Year …
5 days ago HOLLY SPRINGS, N.C., April 22, 2025 – FUJIFILM Diosynth Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, …See details»